Scott R. Barnum - Publications

Affiliations: 
Microbiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Immunology

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ramos TN, Arynchyna AA, Blackburn TE, Barnum SR, Johnston JM. Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children. Jci Insight. 1: e87919. PMID 27699221 DOI: 10.1172/Jci.Insight.87919  0.71
2015 Johnston JM, Ramos TN, Arynchyna AA, Blackburn TE, Amburgy J, Rocque BG, Blount JP, Rozzelle CJ, Oakes J, Barnum SR. 190 Complement Membrane Attack Complex (MAC) Level in CSF Provides Rapid Identification of Shunt Infection and Failure. Neurosurgery. 62: 229. PMID 26182036 DOI: 10.1227/01.Neu.0000467154.21290.7F  0.718
2014 Buckingham SC, Ramos TN, Barnum SR. Complement C5-deficient mice are protected from seizures in experimental cerebral malaria. Epilepsia. 55: e139-42. PMID 25385326 DOI: 10.1111/Epi.12858  0.726
2014 Szalai AJ, Barnum SR, Ramos TN. Deletion of C-reactive protein ameliorates experimental cerebral malaria? Transactions of the Royal Society of Tropical Medicine and Hygiene. 108: 591-3. PMID 25002461 DOI: 10.1093/Trstmh/Tru098  0.716
2014 Ramos TN, Bullard DC, Barnum SR. ICAM-1: isoforms and phenotypes. Journal of Immunology (Baltimore, Md. : 1950). 192: 4469-74. PMID 24795464 DOI: 10.4049/Jimmunol.1400135  0.781
2014 Hu X, Patel RP, Weinberg JA, Marques MB, Ramos TN, Barnum SR. Membrane attack complex generation increases as a function of time in stored blood. Transfusion Medicine (Oxford, England). 24: 114-6. PMID 24588971 DOI: 10.1111/Tme.12109  0.748
2014 Bullard DC, Hu X, Crawford D, McDonald K, Ramos TN, Barnum SR. Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis. European Journal of Immunology. 44: 1194-9. PMID 24435747 DOI: 10.1002/Eji.201344023  0.767
2014 Hu X, Wetsel RA, Ramos TN, Mueller-Ortiz SL, Schoeb TR, Barnum SR. Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis. Immunobiology. 219: 104-8. PMID 24028840 DOI: 10.1016/J.Imbio.2013.08.007  0.802
2013 Read RW, Vogt SD, Barnum SR. The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis. Journal of Neuroimmunology. 264: 127-9. PMID 24035596 DOI: 10.1016/J.Jneuroim.2013.08.010  0.687
2013 Järlestedt K, Rousset CI, StÃ¥hlberg A, Sourkova H, Atkins AL, Thornton C, Barnum SR, Wetsel RA, Dragunow M, Pekny M, Mallard C, Hagberg H, Pekna M. Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 3797-804. PMID 23737250 DOI: 10.1096/Fj.13-230011  0.324
2013 Ramos TN, Bullard DC, Darley MM, McDonald K, Crawford DF, Barnum SR. Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1). The Journal of Biological Chemistry. 288: 10962-6. PMID 23493396 DOI: 10.1074/Jbc.C113.457028  0.761
2013 Hu X, Holers VM, Thurman JM, Schoeb TR, Ramos TN, Barnum SR. Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE. Molecular Immunology. 54: 302-8. PMID 23337717 DOI: 10.1016/J.Molimm.2012.12.018  0.782
2012 Hu X, Tomlinson S, Barnum SR. Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE. Neuroscience Letters. 531: 35-9. PMID 23079547 DOI: 10.1016/J.Neulet.2012.10.012  0.306
2012 Ramos TN, Bullard DC, Barnum SR. Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria. Parasite Immunology. 34: 547-50. PMID 22882618 DOI: 10.1111/Pim.12002  0.771
2012 Darley MM, Ramos TN, Wetsel RA, Barnum SR. Deletion of carboxypeptidase N delays onset of experimental cerebral malaria. Parasite Immunology. 34: 444-7. PMID 22708514 DOI: 10.1111/J.1365-3024.2012.01376.X  0.79
2012 Ramos TN, Darley MM, Weckbach S, Stahel PF, Tomlinson S, Barnum SR. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria. The Journal of Biological Chemistry. 287: 24734-8. PMID 22689574 DOI: 10.1074/Jbc.C112.378364  0.771
2012 Wheeler C, Nabors LB, Barnum S, Yang X, Hu X, Schoeb TR, Chen D, Ardelt AA, King PH. Sex hormone-dependent attenuation of EAE in a transgenic mouse with astrocytic expression of the RNA regulator HuR Journal of Neuroimmunology. 246: 34-37. PMID 22445740 DOI: 10.1016/J.Jneuroim.2012.02.014  0.31
2011 Woehrl B, Brouwer MC, Murr C, Heckenberg SG, Baas F, Pfister HW, Zwinderman AH, Morgan BP, Barnum SR, van der Ende A, Koedel U, van de Beek D. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. The Journal of Clinical Investigation. 121: 3943-53. PMID 21926466 DOI: 10.1172/JCI57522  0.314
2011 Ramos TN, Darley MM, Hu X, Billker O, Rayner JC, Ahras M, Wohler JE, Barnum SR. Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria. Journal of Immunology (Baltimore, Md. : 1950). 186: 6657-60. PMID 21572031 DOI: 10.4049/Jimmunol.1100603  0.806
2011 Hu XZ, Wright TT, Jones NR, Ramos TN, Skibinski GA, McCrory MA, Barnum SR, Szalai AJ. Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent. Autoimmune Diseases. 2011: 484936. PMID 21151582 DOI: 10.4061/2011/484936  0.787
2010 Ingersoll SA, Martin CB, Barnum SR, Martin BK. CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model. Molecular Immunology. 48: 219-30. PMID 20813409 DOI: 10.1016/J.Molimm.2010.08.007  0.376
2010 Hu X, Barnum SR, Wohler JE, Schoeb TR, Bullard DC. Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis. Molecular Immunology. 47: 1692-700. PMID 20371120 DOI: 10.1016/J.Molimm.2010.03.005  0.801
2010 Hu X, Wohler JE, Dugger KJ, Barnum SR. beta2-integrins in demyelinating disease: not adhering to the paradigm. Journal of Leukocyte Biology. 87: 397-403. PMID 20007244 DOI: 10.1189/Jlb.1009654  0.796
2010 Wohler JE, Smith SS, Barnum SR. gammadelta T cells: the overlooked T-cell subset in demyelinating disease. Journal of Neuroscience Research. 88: 1-6. PMID 19610090 DOI: 10.1002/Jnr.22176  0.789
2009 Ramos TN, Wohler JE, Barnum SR. Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis. Neuroscience Letters. 467: 234-6. PMID 19850104 DOI: 10.1016/J.Neulet.2009.10.045  0.835
2009 Wohler J, Bullard D, Schoeb T, Barnum S. LFA-1 is critical for regulatory T cell homeostasis and function. Molecular Immunology. 46: 2424-8. PMID 19428111 DOI: 10.1016/J.Molimm.2009.04.004  0.732
2009 Wohler JE, Smith SS, Zinn KR, Bullard DC, Barnum SR. Gammadelta T cells in EAE: early trafficking events and cytokine requirements. European Journal of Immunology. 39: 1516-26. PMID 19384874 DOI: 10.1002/Eji.200839176  0.804
2009 Osmers I, Smith SS, Parks BW, Yu S, Srivastava R, Wohler JE, Barnum SR, Kabarowski JH. Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 207: 18-23. PMID 19135725 DOI: 10.1016/J.Jneuroim.2008.11.008  0.818
2009 Dugger KJ, Zinn KR, Weaver C, Bullard DC, Barnum SR. Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 206: 22-7. PMID 19010554 DOI: 10.1016/J.Jneuroim.2008.10.006  0.81
2009 Wohler JE, Barnum SR. Nylon wool purification alters the activation of T cells. Molecular Immunology. 46: 1007-10. PMID 18952296 DOI: 10.1016/J.Molimm.2008.09.017  0.76
2008 Smith SS, Barnum SR. Differential expression of β2 -integrins and cytokine production between γδ and αβ T cells in experimental autoimmune encephalomyelitis. Journal of Leukocyte Biology. 83: 71-79. PMID 29350828 DOI: 10.1189/jlb.0407263  0.346
2008 Smith SS, Ludwig M, Wohler JE, Bullard DC, Szalai AJ, Barnum SR. Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice. Neuroscience Letters. 442: 158-60. PMID 18634851 DOI: 10.1016/J.Neulet.2008.07.005  0.817
2008 Smith SS, Barnum SR. Differential expression of beta 2-integrins and cytokine production between gammadelta and alphabeta T cells in experimental autoimmune encephalomyelitis. Journal of Leukocyte Biology. 83: 71-9. PMID 17928460 DOI: 10.1189/Jlb.0407263  0.323
2007 Briggs DT, Martin CB, Ingersoll SA, Barnum SR, Martin BK. Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model. Glia. 55: 1405-15. PMID 17674370 DOI: 10.1002/Glia.20551  0.386
2007 Bullard DC, Hu X, Adams JE, Schoeb TR, Barnum SR. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis. The American Journal of Pathology. 170: 2001-8. PMID 17525267 DOI: 10.2353/Ajpath.2007.061016  0.382
2007 Szalai AJ, Hu X, Adams JE, Barnum SR. Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease. Molecular Immunology. 44: 3132-6. PMID 17353050 DOI: 10.1016/J.Molimm.2007.02.002  0.416
2007 Adams JE, Webb MS, Hu X, Staunton D, Barnum SR. Disruption of the beta2-integrin CD11d (alphaDbeta2) gene fails to protect against experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 184: 180-7. PMID 17254640 DOI: 10.1016/J.Jneuroim.2006.12.007  0.38
2007 Bullard DC, Hu X, Schoeb TR, Collins RG, Beaudet AL, Barnum SR. Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 178: 851-7. PMID 17202346 DOI: 10.4049/Jimmunol.178.2.851  0.362
2006 Axtell RC, Xu L, Barnum SR, Raman C. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. Journal of Immunology (Baltimore, Md. : 1950). 177: 8542-9. PMID 17142752 DOI: 10.4049/Jimmunol.177.12.8542  0.344
2006 Vogt SD, Barnum SR, Curcio CA, Read RW. Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina. Experimental Eye Research. 83: 834-40. PMID 16764856 DOI: 10.1016/J.Exer.2006.04.002  0.599
2006 Read RW, Vogt SD, Barnum SR, Szalai AJ. Experimental autoimmune uveitis in the C57BL/6 mouse. Experimental Eye Research. 83: 229-30; author reply. PMID 16524572 DOI: 10.1016/j.exer.2005.10.028  0.601
2006 Barnum SR, Szalai AJ. Complement and demyelinating disease: no MAC needed? Brain Research Reviews. 52: 58-68. PMID 16443278 DOI: 10.1016/J.Brainresrev.2005.12.002  0.402
2006 Read RW, Szalai AJ, Vogt SD, McGwin G, Barnum SR. Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis. Experimental Eye Research. 82: 389-94. PMID 16143328 DOI: 10.1016/J.Exer.2005.07.011  0.69
2005 Szalai AJ, Hu X, Raman C, Barnum SR. Requirement of the Fc receptor common gamma-chain for gamma delta T cell-mediated promotion of murine experimental autoimmune encephalomyelitis. European Journal of Immunology. 35: 3487-92. PMID 16278814 DOI: 10.1002/Eji.200535285  0.325
2005 Bullard DC, Hu X, Schoeb TR, Axtell RC, Raman C, Barnum SR. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 175: 6327-33. PMID 16272284 DOI: 10.4049/Jimmunol.175.10.6327  0.413
2005 Reiman R, Campos Torres A, Martin BK, Ting JP, Campbell IL, Barnum SR. Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis. Neuroscience Letters. 390: 134-8. PMID 16154690 DOI: 10.1016/J.Neulet.2005.08.022  0.827
2005 Boos L, Szalai AJ, Barnum SR. C3a expressed in the central nervous system protects against LPS-induced shock. Neuroscience Letters. 387: 68-71. PMID 16085360 DOI: 10.1016/J.Neulet.2005.07.015  0.833
2005 Osmers I, Bullard DC, Barnum SR. PSGL-1 is not required for development of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 166: 193-6. PMID 16005524 DOI: 10.1016/J.Jneuroim.2005.06.001  0.326
2005 Nicholas AP, Sambandam T, Echols JD, Barnum SR. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis. The Journal of Comparative Neurology. 486: 254-66. PMID 15844173 DOI: 10.1002/Cne.20527  0.312
2005 Boos LA, Szalai AJ, Barnum SR. Murine complement C4 is not required for experimental autoimmune encephalomyelitis. Glia. 49: 158-60. PMID 15390104 DOI: 10.1002/Glia.20093  0.826
2004 Boos L, Campbell IL, Ames R, Wetsel RA, Barnum SR. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 173: 4708-14. PMID 15383607 DOI: 10.4049/Jimmunol.173.7.4708  0.837
2004 Axtell RC, Webb MS, Barnum SR, Raman C. Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice. Journal of Immunology (Baltimore, Md. : 1950). 173: 2928-32. PMID 15322150 DOI: 10.4049/Jimmunol.173.5.2928  0.372
2004 Szalai AJ, Barnum SR. Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. Journal of Neuroscience Research. 75: 597-602. PMID 14991835 DOI: 10.1002/Jnr.20023  0.384
2002 Szalai AJ, Nataf S, Hu XZ, Barnum SR. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. Journal of Immunology (Baltimore, Md. : 1950). 168: 5792-7. PMID 12023381 DOI: 10.4049/Jimmunol.168.11.5792  0.368
2002 Reiman R, Gerard C, Campbell IL, Barnum SR. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis. European Journal of Immunology. 32: 1157-63. PMID 11932923 DOI: 10.1002/1521-4141(200204)32:4<1157::Aid-Immu1157>3.0.Co;2-M  0.837
2000 Nataf S, Carroll SL, Wetsel RA, Szalai AJ, Barnum SR. Attenuation of experimental autoimmune demyelination in complement-deficient mice. Journal of Immunology (Baltimore, Md. : 1950). 165: 5867-73. PMID 11067947 DOI: 10.4049/Jimmunol.165.10.5867  0.402
2000 Campos-Torres A, Reiman R, Martin B, Campbell I, Barnum S. Characterization of transgenic mice over expressing the complement anaphylatoxin C5a in the CNS Immunopharmacology. 49: 48. DOI: 10.1016/S0162-3109(00)80142-3  0.763
1998 Paradisis PM, Campbell IL, Barnum SR. Elevated complement C5a receptor expression on neurons and glia in astrocyte-targeted interleukin-3 transgenic mice Glia. 24: 338-345. PMID 9775985 DOI: 10.1002/(Sici)1098-1136(199811)24:3<338::Aid-Glia8>3.0.Co;2-Y  0.329
1995 Barnum SR. Complement biosynthesis in the central nervous system Critical Reviews in Oral Biology and Medicine. 6: 132-146. PMID 7548620 DOI: 10.1177/10454411950060020301  0.342
Show low-probability matches.